Journal
CLINICAL MICROBIOLOGY AND INFECTION
Volume 14, Issue 12, Pages 1173-1176Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1469-0691.2008.02100.x
Keywords
Diagnostics; Europe; multicentre; nucleic amplification technique; quality control; respiratory syncytial virus; sensitivity
Categories
Funding
- Federal Office for Public Health, Switzerland
- F. Hofmann-La Roche Ltd
- Sanofi Pasteur and Sanofi Pasteur MSD
Ask authors/readers for more resources
The performance of nucleic acid amplification techniques for detecting respiratory syncytial virus (RSV) was evaluated in 25 laboratories across Europe by an external quality assessment study. In addition, factors related to the diagnostic performance of laboratories were explored. The results of this quality control study show that the performance of laboratories for RSV diagnosis in Europe is good, with an overall correct score of 88%. The type of assay (nested or real-time PCR vs. commercial tests) was identified as a significant factor (OR 8.39; 95% CI 1.91-36.78) in predicting a correct result.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available